Perrysburg, OH, United States of America

John D Dignam

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Medical College of Ohio. Active years: 2006-2009.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2006-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator in Medicine: John D. Dignam

Introduction

John D. Dignam is a prominent inventor based in Perrysburg, Ohio, recognized for his significant contributions to the medical field. With a total of three patents to his name, his innovations primarily focus on compositions aimed at treating critical medical conditions.

Latest Patents

Among his latest achievements, Dignam secured a patent for an "Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction." This invention comprises an albumin-based colloid designed to address hypovolemic conditions, such as capillary leak syndrome and shock. His work provides essential insights into effective treatments, proving vital in emergency medical situations.

Career Highlights

Dignam is affiliated with the Medical College of Ohio, where he continues to explore innovative solutions to improve patient care. His dedication to research and development underscores his commitment to advancing medical technology.

Collaborations

Throughout his career, Dignam has collaborated with esteemed colleagues, including Ragheb A. Assaly and Joseph I. Shapiro. These collaborations have enriched his research and led to groundbreaking discoveries in medical applications.

Conclusion

John D. Dignam's contributions to the field of medicine through his patents reflect a deep commitment to innovation and improving health outcomes. As he continues his work at the Medical College of Ohio, his inventions are paving the way for future medical advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…